Clinical Trials Directory

Trials / Completed

CompletedNCT00438945

The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension

The Effect of Eprosartan in Patients With Essential Hypertension on Renal Tubular Function and Vasoactive Hormones During Baseline Conditions and After Activation of the Sympathetic Nervous System.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
Regional Hospital Holstebro · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

We, the investigators at Holstebro Hospital, want to test the hypothesis that eprosartan reduces the activity of the sympathetic nervous system in patients with essential hypertension - during baseline conditions and after activation of the sympathetic nervous system.

Conditions

Interventions

TypeNameDescription
DRUGEprosartan

Timeline

Start date
2007-01-01
Completion
2008-01-01
First posted
2007-02-22
Last updated
2008-05-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00438945. Inclusion in this directory is not an endorsement.

The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension (NCT00438945) · Clinical Trials Directory